The minimally invasive spine surgery market is expected to reach $4.16 billion globally, according to a market research report from DataM intelligence.
Five notes:
1. The global MISS market reached $2.67 billion in 2022 and is expected to grow to $4.16 billion, or 5.8% CAGR, by 2031.
2. Market growth is driven by increased prevalence for spinal disorders, aging populations and demand for faster surgical recovery.
3. North America leads the global market share with 35%.
4. The U.S. MISS market is expected to reach $1.2 billion by 2031.
5. Key companies in the MISS market include Zimmer Biomet, DePuy Synthes, Stryker and Medtronic.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
